Cargando…
Pain Modulation in Chronic Musculoskeletal Disorders: Botulinum Toxin, a Descriptive Analysis
Botulinum neurotoxin (BoNT), a product of Clostridium botulinum, reversibly inhibits the presynaptic release of the neurotransmitter acetylcholine at the neuromuscular junction. In addition, BoNT blocks the transmission of other substances involved in pain perception and, together with a soft-tissue...
Autores principales: | Poenaru, Daniela, Sandulescu, Miruna Ioana, Cinteza, Delia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376837/ https://www.ncbi.nlm.nih.gov/pubmed/37509527 http://dx.doi.org/10.3390/biomedicines11071888 |
Ejemplares similares
-
Intraarticular management of chronic haemophilic arthropathy (Review)
por: Poenaru, Daniela, et al.
Publicado: (2023) -
Biological effects of extracorporeal shockwave therapy in tendons: A systematic review
por: Poenaru, Daniela, et al.
Publicado: (2022) -
Conservative therapy in ulnar neuropathy at the elbow (Review)
por: Poenaru, Daniela, et al.
Publicado: (2022) -
Use of botulinum toxin in musculoskeletal pain
por: Singh, Jasvinder A
Publicado: (2013) -
Use of botulinum toxin-A for musculoskeletal pain in patients with whiplash associated disorders [ISRCTN68653575]
por: Juan, Francisco J
Publicado: (2004)